Quantcast
Last updated on April 17, 2014 at 9:08 EDT

Latest Diabetes mellitus type 1 Stories

2013-06-25 08:29:43

Baseline characteristics of patients enrolled in a separate CV outcome study comparing linagliptin with glimepiride also published in the American Diabetes Association 73rd Scientific Sessions® abstract book RIDGEFIELD, Conn. and INDIANAPOLIS, June 25, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced results from a new pooled analysis of phase III data for the dipeptidyl peptidase-4 (DPP-4) inhibitor...

2013-06-24 11:33:53

Development continues with data presented at the American Diabetes Association Animas Corporation announced today further promising results from the second phase of human clinical trials of a first-generation closed-loop insulin delivery system in development. Data investigating the predictive Hypoglycemia-Hyperglycemia Minimizer (HHM) System demonstrated that the system is capable of maintaining safe glucose levels overnight. The data was presented at the 73rd Scientific Sessions of the...

2013-06-24 08:27:37

CHICAGO, June 24, 2013 /CNW/ - Results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2(TM)) show that 28 per cent of Canadians living with diabetes have experienced significant emotional distress and 15 per cent have felt discriminated against due to their disease.(1,5) Results from the DAWN2(TM) study were presented today at the 73(rd) Scientific Sessions of the American Diabetes Association (ADA).(2-9) DAWN2(TM) represents opinions from more than 15,000 people...

2013-06-24 08:27:36

NEW YORK, June 24, 2013 /PRNewswire/ -- Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies for people with diabetes, announces that its technologies were featured at the American Diabetes Association annual meeting. The presentations were made in part by members of Islet's Scientific Advisory Board, which included Dr. Jonathan Lakey, Dr. Kevan Harold and Dr. Eitan Akirav. Sessions...

2013-06-24 04:20:50

CHICAGO, June 24, 2013 /PRNewswire/ -- Key results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2(TM)) show that one in five people with diabetes feel discriminated against because of their condition, and support from the broader community is scarce.(1,2) Results from the DAWN2(TM) study were presented today at the 73(rd) Scientific Sessions of the American Diabetes Association (ADA).(1-11) (Logo: http://photos.prnewswire.com/prnh/20110414/NY80976LOGO )...

2013-06-22 12:21:35

- EDITION I demonstrated similar blood sugar control with fewer night-time low blood sugar events compared to Lantus® - PARIS, June 22, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the first Phase 3 study results (EDITION I) for its investigational new insulin U300 showed equivalent blood sugar control with fewer night-time low blood sugar events compared to Lantus(® )(insulin glargine [rDNA origin] injection). The company also announced topline...

2013-06-22 12:21:24

CHICAGO, June 22, 2013 /PRNewswire-USNewswire/ -- Cities for Life, a diabetes management program in Birmingham, Ala. led by the American Academy of Family Physicians Foundation with support from Sanofi US, announced today initial findings on the diabetes self-management program at the American Diabetes Association's 73rd Scientific Sessions. Three analyses of the data are being either presented or published at the five-day conference. With nearly 26 million people living with...

2013-06-22 12:21:03

Lower incidence of hypoglycemia observed when linagliptin is added to basal insulin in elderly patients and with linagliptin treatment vs. glimepiride, according to two presentations at the American Diabetes Association 73rd Scientific Sessions® RIDGEFIELD, Conn. and INDIANAPOLIS, June 22, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced results from two exploratory analyses assessing the risk of hypoglycemia with...

2013-06-22 12:20:56

Studies assessing linagliptin alone and in combination with metformin in people with type 2 diabetes from China, Malaysia and the Philippines presented at the American Diabetes Association 73rd Scientific Sessions® RIDGEFIELD, Conn. and INDIANAPOLIS, June 22, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced results from two phase III clinical studies that showed linagliptin in Asian adults, as monotherapy and in...

2013-06-22 12:20:13

Data to be Presented at the 73rd American Diabetes Association Scientific Sessions® Further Explore Mealtime Insulin Requirements in Patients with Type 1 Diabetes CHICAGO, June 22, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results from an additional analysis of Phase II clinical data for LY2605541, an investigational novel basal insulin analog. The analysis provides more in-depth information about the reductions in required prandial (mealtime) insulin in...


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »